Limiting inpatient substance use treatment: What are the consequences?

Medical Care Research and Review

Volumn 60, Issue 3, 2003, Pages 332-346

  Dickey, Barbara ^a   Normand, Sharon Lise T ^b   Weiss, Roger D ^c   Azeni, Hocine ^b   Drake, Robert ^b   Hanson, Annette ^b  

^a CAMBRIDGE HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Dual disorders; Managed care; Serious mental illness; Substance use disorders

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MENTAL DISEASE; MOOD DISORDER; MULTIVARIATE ANALYSIS; OUTPATIENT CARE; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AMBULATORY CARE; COST ALLOCATION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MALE; MANAGED CARE PROGRAMS; MASSACHUSETTS; MEDICAID; MENTAL HEALTH SERVICES; MIDDLE AGED; MOOD DISORDERS; REIMBURSEMENT, INCENTIVE; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 0041520902     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/1077558703254691     Document Type: Article

References (36)

1. Abram, K. M., and L. A. Teplin. 1991. Co-occurring disorders among mentally ill jail detainees: Implications for public policy. American Psychologist 46:1036-45.
2. Barrowclough, C., G. Haddock, N. Tarrier, S. Lewis, J. Moring, S. O'Brien, N. Schofield, and J. McGovern. 2001. Randomized controlled trial of motivational interviewing and cognitive behavioral intervention for schizophrenia patients with associated drug or alcohol misuse. American Journal of Psychiatry 158:1706-13.
3. Bartels, S. J., G. B. Teague, R. E. Drake, R. E. Clark, P. W. Bush, and D. L. Noordsy. 1993. Service utilization and costs associated with substance abuse among rural schizophrenic patients. Journal of Nervous and Mental Disease 181:227-32.
4. Bradley, C. J., and G. A. Zarkin. 1996. Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse. Health Services Research 31:387-407.
5. Brady, K. T., and R. B. Lydiard. 1992. Bipolar affective disorder and substance abuse. Journal of Clinical Psychopharmacology 12 (supp. 1): 17s-22s.
6. Callahan, J. J., D. S. Shepard, R. H. Beinecke, M. J. Larson, and D. Cavanaugh. 1995. Mental health/substance abuse in managed care: the Massachusetts Medicaid experience. Health Affairs 14:173-84.
7. Caton, C. L. 1981. The new chronic patient and the system of community care. Hospital and Community Psychiatry 32:475-78.
8. Caton, C. L., P. E. Shrout, P. F. Eagle, L. A. Opler, A. Felix, and B. Dominguez. 1994. Risk factors for homelessness among schizophrenic men: A case-control study. American Journal of Public Health 84:265-70.
9. Cuffel, B., M. Shumway, and T. Chouljian. 1994. A longitudinal study of substance use and community violence in schizophrenia. Journal of Nervous Mental Disease 182:704-8.
10. Dickey, B., and H. Azeni. 1993. Cost-containment in mental health care: The role of utilization review. Advances in Health Economics and Health Services Research 14:197-207.
11. -. 1996. Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care. American Journal of Public Health 86:973-77.
12. Dickey, B., E. Norton, S. L. Normand, H. Azeni, W. Fisher, and F. Altaffer. 1995. Massachusetts Medicaid managed health care reform: Treatment for the psychiatrically disabled. Advances in Health Economics and Health Services Research 15:99-117.
13. Dixon, L. 1999. Dual diagnoses of substance abuse and schizophrenia: Prevalence and impact on outcomes. Schizophrenia Research 35:S93-S100.
14. Drake, R. E., S. Essock, A. Shaner, K. B. Carey, K. Minkoff, L. Kola, D. Lynde, F. C. Osher, R. E. Clark, and L. Rickards. 2001. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services 52:469-76.
15. Drake, R. E., C. Mercer-McFadden, K. T. Mueser, G. J. McHugo, and G. R. Bond. 1998. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 24:589-608.
16. Drake, R. E., and M. A. Wallach. 2000. Dual diagnosis: 15 years of progress. Psychiatric Services 51:1126-29.
17. Drake, R. E., N. A. Yovetich, and R. R. Bebout. 1997. Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease 185:298-305.
18. Duan, N. 1983. Smearing estimate: A nonparametric retransformation method. Journal of the American Statistical Association 78 (303): 605-10.
19. Fisher, W. H., B. Dickey, S. L. Normand, I. K. Packer, A. J. Grudzinskas, and H. Azeni. 2002. Use of a state inpatient forensic system under managed mental health care. Psychiatric Services 53:447-51.
20. Garnick, D. W., A. M. Hendricks, M. L. Drainoni, C. M. Horgan, and C. Comstock. 1996. Private sector coverage of people with dual diagnoses. Journal of Mental Health Administration 23:317-28.
21. Godley, S. H., R. Hoewing-Roberson, and M. D. Godley. 1994. Final MISA report. Bloomington, IL: Lighthouse Institute.
22. Haywood, T. W., H. M. Kravitz, L. S. Grossman, O. E. Wasyliw, and D. W. Hardy. 1995. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry 152:856-61.
23. Hoff, R. A., and R. A. Rosenheck. 1999. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services 50:1309-15.
24. Holder, H. D., R. Longabaugh, W. R. Miller, and A. V. Rubonis. 1992. The cost effectiveness of treatment for alcoholism: A first approximation. Journal of Studies on Alcohol 52:517-40.
25. Jerrell, J. M., and M. S. Ridgely. 1995. Comparative effectiveness of three approaches to serving people with severe mental illness and substance use disorders. Journal of Nervous and Mental Disease 183:566-76.
26. Kessler R. C., C. B. Nelson, K. A. McGonagle, M. J. Edlund, R. G. Frank, and P. J. Leaf. 1996. The epidemiology of co-occurring addictive and mental disorders. American Journal of Orthopsychiatry 66:17-30.
27. McLellan, A. T., D. Metzger, A. L. Alterman, J. Cornish, and H. Urschel. 1992. How effective is substance abuse treatment - Compared to what? In Advances in understanding addictive states, edited by C. P. O'Brien and J. Jaffee, 232-52. New York: Association for Research in Nervous and Mental Disease.
28. Mueser, K. T., R. E. Drake, and M. A. Wallach. 1998. Dual diagnosis: A review of etiological theories. Addiction Behavior 23:717-34.
29. Pepper, B., M. C. Krishner, and H. Ryglewicz. 1981. The young adult chronic patient: Overview of a population. Hospital and Community Psychiatry 32:463-69.
30. Regier, D. A., M. E. Farmer, D. S. Rae, B. Z. Locke, S. J. Keith, L. L. Judd, and F. K. Goodwin. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association 264:2511-18.
31. Ridgely, M. S., H. H. Goldman, and M. Willenbring. 1990. Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin 16:123-32.
32. Ridgely, M. S., F. C. Osher, H. H. Goldman, and J. A. Talbott. 1987. Executive summary: Chronic mentally ill young adults with substance abuse problems: A review of reseach, treatment, and training issues. Baltimore: Mental Health Services Research Center, University of Maryland School of Medicine.
33. Ries, R. K., J. Russo, D. Wingerson, M. Snoden, K. A. Comtois, D. Srebnik, and P. RoyByrne. 2000. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance use disorders. Psychiatric Services 51:210-15.
34. Rosenberg, S. D., L. A. Goodman, F. C. Osher, M. S. Shwartz, S. M. Essock, M. I. Butterfield, N. T. Constantine, G. L. Wolford, and M. P. Salyers. 2001. Prevalence of HW, hepatitis B and hepatitis C in people with severe mental illness. American Journal of Public Health 91:31-37.
35. Safer, D. J. 1987. Substance abuse by young adult chronic patients. Hospital and Community Psychiatry 38:511-14.
36. Swofford, C., J. W. Kasckow, G. Scheller-Gilkey, and L. B. Inderbitzin. 1996. Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research 20:145-51.